Poland· PL-100346646

Atozet

A atorvastatin and ezetimibe product containing ezetimibum + atorvastatinum, registered in Poland by Organon Polska Sp. z o.o.. The same ATC class is registered in 10 of our 19 countries.

ATC C10BA05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAtozetATCC10BA05REGISTER NO.PL-100346646PACKS LISTED6CHECKEDSeptember 20, 2026

Where it is registered

Atorvastatin and ezetimibe is registered in 10 of 19 countries.

Countries holding a registration under ATC C10BA05 (atorvastatin and ezetimibe), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Atorvastatin and ezetimibe · ATC C10BA05

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ezetimibum + Atorvastatinum
Manufacturer
Organon Polska Sp. z o.o.
Country
Poland (PL)
ATC code
C10BA05
ATC class
Atorvastatin and ezetimibe
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 20, 2026

Packs & prices · 6

  • gtin
    05909991226459
  • gtin
    05909991226466
  • gtin
    05909991226473
  • gtin
    05909991226480
  • gtin
    05909991226497
  • gtin
    05909991226503

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for atorvastatin and ezetimibe.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Atorvastatin and ezetimibe · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Atorvastatin and ezetimibe in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All atorvastatin and ezetimibe products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Atorvacor + Ezetimib, Atozet
  • Belgium · Atozet, Ezetimibe/Atorvastatin Krka
  • Bulgaria · Аванор Плюс, Зетовар
  • Cyprus · Amicor Plus, Atoritimb
  • Czechia · Amedo Plus, Atoris Plus
  • Germany · Atorimib, Atozet
  • Denmark · Atozet
  • Estonia · Atoritimb, Atorvastatin/Ezetimibe Teva
  • Spain · Atorduo, Atorvastatina/Ezetimiba Cinfa
  • Finland · Ezetimib/Atorvastatin Krka
  • France · Ezetimibe / Atorvastatine Biogaran, Ezetimibe/Atorvastatine Arrow
  • United Kingdom (Northern Ireland) · Atozet
  • Greece · Ancilleg, Ator-Chol Plus
  • Croatia · Altrexyl, Artas Plus
  • Hungary · Atoris Plus, Cholezta
  • Ireland · Atozet, Ezetimibe/Atorvastatin
  • Iceland · Ezetimibe/Atorvastatin Stada
  • Italy · Ancilleg, Athemibe
  • Lithuania · Aterezim, Atorvastatin/Ezetimibe Teva
  • Luxembourg · Atozet, Ezetimib/Atorvastatin Ratiopharm
  • Latvia · Aterezim, Atorvastatin/Ezetimibe Teva
  • Malta · Amicor Plus, Atozet
  • Netherlands · Atozet, Ezeat
  • Portugal · Atorduo, Atorvastatina + Ezetimiba Alter
  • Romania · Co-Atoris, Coleatez
  • Sweden · Atozet, Ezetimib/Atorvastatin Krka
  • Slovenia · Aterezim, Ezetimib/Atorvastatin Alkaloid-Int
  • Slovakia · Atoritimb, Atorvastatín/Ezetimib Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee949c75-4836-4428-a6c4-826a0ca3c99e
GET /v1/drugs/ee949c75-4836-4428-a6c4-826a0ca3c99e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "10 mg + 10 mg",
  "packaging": "05909991226459 ¦ Rp ¦ 108996\n10 tabl.\n05909991226466 ¦ Rp ¦ 108997\n30 tabl. w blistrze\n05909991226473 ¦ Rp ¦ 108998\n30 tabl. w blistrze perforowanym\n05909991226480 ¦ Rp ¦ 108999\n45 tabl.\n05909991226497 ¦ Rp ¦ 109000\n90 tabl.\n05909991226503 ¦ Rp ¦ 109001\n100 tabl.",
  "substance": "Ezetimibum 10 mg + Atorvastatinum 10 mg",
  "common_name": "Ezetimibum + Atorvastatinum",
  "pl_product_id": "100346646",
  "pozwolenie_nr": "22521",
  "auth_procedure": "DCP",
  "authorisation_validity": "2023-09-22"
}

See everything about atorvastatin and ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.